Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Size & Outlook

The clinical trial biorepository & archiving solutions market in Asia Pacific is expected to reach a projected revenue of US$ 1,211.9 million by 2030. A compound annual growth rate of 14.5% is expected of Asia Pacific clinical trial biorepository & archiving solutions market from 2024 to 2030.
Revenue, 2023 (US$M)
$468.5
Forecast, 2030 (US$M)
$1,211.9
CAGR, 2024 - 2030
14.5%
Report Coverage
Asia Pacific

Asia Pacific clinical trial biorepository & archiving solutions market, 2018-2030 (US$M)

Asia
Unlock Premium

Related Markets

Asia Pacific clinical trial biorepository & archiving solutions market highlights

  • The Asia Pacific clinical trial biorepository & archiving solutions market generated a revenue of USD 468.5 million in 2023.
  • The market is expected to grow at a CAGR of 14.5% from 2024 to 2030.
  • In terms of segment, biorepository services was the largest revenue generating service in 2023.
  • Biorepository Services is the most lucrative service segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 468.5 million
Market revenue in 2030USD 1,211.9 million
Growth rate14.5% (CAGR from 2023 to 2030)
Largest segmentBiorepository services
Fastest growing segmentBiorepository Services
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiorepository Services, Archiving Solution Services
Key market players worldwideAzenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 11.7% of the global clinical trial biorepository & archiving solutions market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,211.9 million by 2030.

Biorepository services was the largest segment with a revenue share of 66.34% in 2023. Horizon Databook has segmented the Asia Pacific clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.


Asia Pacific is expected to be one of the fastest growing regions in clinical trial biorepository & archiving solutions market. The tremendous growth in clinical research is expected to drive growth of clinical trial biorepository & archiving solutions market in the region.

Primary factors driving the growth of clinical research in these regions include low cost per patient in Asia Pacific countries and presence of a diverse group of patients that are easy to recruit.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Biorepository & Archiving Solutions Market Companies

Name Profile # Employees HQ Website

Asia Pacific clinical trial biorepository & archiving solutions market size, by country, 2018-2030 (US$M)

Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific clinical trial biorepository & archiving solutions market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more